Posted by Christopher Mengel on Dec 3rd, 2024
Ikarian Capital LLC reduced its holdings in Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) by 47.5% during the third quarter, Holdings Channel.com reports. The fund owned 55,175 shares of the company’s stock after...
More of this article »